Clinical Trials Logo

Pneumonia, Mycoplasma clinical trials

View clinical trials related to Pneumonia, Mycoplasma.

Filter by:

NCT ID: NCT06392451 Not yet recruiting - Clinical trials for Coronavirus Disease 2019

LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia

Start date: May 6, 2024
Phase: N/A
Study type: Interventional

To establish the relative accuracy of the LIAISON® NES Flu A/B, RSV & COVID-19 assay for viral nucleic acid targets from professionally collected or patient self-collected dry nasal (NS) swabs and to establish the relative accuracy of the LIAISON PLEX® RSP Flex assay from NS and nasopharyngeal swabs (NPS) in applicable transport media from human patients exhibiting clinical signs and symptoms of a respiratory tract infection.

NCT ID: NCT06348095 Not yet recruiting - Clinical trials for Mycoplasma Pneumoniae Pneumonia

Effect of Probiotics on Mycoplasma Pneumoniae Pneumonia

Start date: May 27, 2024
Phase: N/A
Study type: Interventional

To evaluate the effectiveness and safety of compound probiotic in shortening the course of illness in children with mycoplasma pneumoniae pneumonia, in comparison with placebo.

NCT ID: NCT06325293 Not yet recruiting - Clinical trials for Mycoplasma Pneumoniae Pneumonia

A Trial of Placebo Versus Macrolide for Mycoplasma Pneumoniae Childhood Pneumonia: MYTHIC Study

MYTHIC
Start date: July 1, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare a placebo (a look-alike substance that contains no active drug) with a commonly used antibiotic in children with Mycoplasma pneumoniae (a specific bacterium) induced community-acquired pneumonia. The main question it aims to answer is: Is antibiotic treatment needed in Mycoplasma pneumoniae (a specific bacterium) induced pneumonia? Participants will receive either a placebo or a antibiotic treatment and track their symptoms and vital signs until they are healthy. Researchers will then compare the length of symptoms between the placebo and the antibiotic group.

NCT ID: NCT04296383 Not yet recruiting - Clinical trials for Mycoplasma Pneumoniae Pneumonia

Xiyanping Injection Combined With Azithromycin VS Azithromycin for Children With pneumoniaProtozoal Pneumonia

Start date: June 15, 2020
Phase: N/A
Study type: Interventional

Mycoplasma pneumoniae pneumonia in children is one of the major diseases in children's respiratory department in China, but there are still large clinical unmet needs.

NCT ID: NCT04043325 Recruiting - Clinical trials for Community-acquired Pneumonia

Diagnosis of Mycoplasma Pneumoniae Infection With Detection of Specific Antibody-secreting Cells in Community-acquired Pneumonia (CAP) Patients of the Randomised Placebo-controlled Multi-centre Effectiveness Trial of Adjunct Betamethasone Therapy

myKIDS-STEP
Start date: May 20, 2019
Phase:
Study type: Observational

To compare presence and kinetics of Mycoplasma pneumoniae (Mp)-specific immunoglobulin (Ig) M antibody-secreting cells (ASCs) with Mp DNA and Mp-specific IgM antibodies in patients with community-acquired pneumonia (CAP) of the KIDS-STEP study.

NCT ID: NCT03911440 Recruiting - Atypical Pneumonia Clinical Trials

Treatment and Vaccine Development of Mycoplasma Pneumoniae

Start date: November 10, 2018
Phase: N/A
Study type: Interventional

A randomized clinical trial comparing treatment effectiveness of azithromycin and doxycycline for pediatric Mycoplasma pneumonia.

NCT ID: NCT03613636 Completed - Diagnosis Clinical Trials

Evaluation of Pathogenesis and Diagnosis of Mycoplasma Pneumoniae Community-acquired Pneumonia (CAP)

myCAP
Start date: May 1, 2016
Phase:
Study type: Observational

To investigate the Mycoplasma pneumoniae-specific circulating antibody-secreting cell (ASC) response and Mycoplasma pneumoniae-specific interferon (INF)-γ-secreting T cell response, along with polymerase chain reaction (PCR) and serology, in a cohort of children with community-acquired pneumonia (CAP) and controls.

NCT ID: NCT03530319 Recruiting - Clinical trials for Pneumonia, Mycoplasma

Treatment of Macrolide-resistant Mycoplasma Pneumoniae

Start date: November 10, 2018
Phase: N/A
Study type: Interventional

A randomized clinical trial comparing treatment effectiveness of azithromycin and doxycycline for pediatric Mycoplasma pneumonia.

NCT ID: NCT02618057 Recruiting - Clinical trials for Mycoplasma Pneumoniae Pneumonia

Effects of Oral Steroid in Mycoplasma Pneumoniae Pneumonia

Start date: June 2016
Phase: Phase 4
Study type: Interventional

Mycoplasma pneumoniae is one of the most common causes of community-acquired pneumonia in children. The clinical course is typically self-limited and benign; however, rare cases of severe pneumonia can develop despite appropriate antibiotic therapy. The investigators aim to study the effects of prednisolone on severe M. pneumoniae pneumonia with lobar consolidation or pleural effusion in children.

NCT ID: NCT02511262 Completed - Clinical trials for Mycoplasma Pneumoniae

Detection of Mycoplasma Pneumoniae

Start date: August 2015
Phase: N/A
Study type: Observational

The objective of this Clinical Trial is to define the methods to be used to document that illumigene® Mycoplasma Direct meets its intended use claims, using the illumipro instrument, with throat swab samples collected from symptomatic patients.